Grifols Stock Price (NASDAQ:GRFS)

Add to My Stocks
$21.03 $0.61 (2.99%) GRFS stock closing price Sep 18, 2018 (Closing)
Prev Close* : $20.42
Market Cap:
$13.94B
Day Low: $20.49
52 Week Low: $19.85
Open: $20.51
Volume: -
Day High: $21.07
52 Week High: $25.18
Dividend:
0.39

Latest Stock Market News

Latest Articles

Grifols News - From Partners

GRFS Stockcharts

View GRFS PE ratio, PS ratio stocks charts and compare with peers.
GRFS Chart
Note: Compare Grifols stock price history with the index and industry peers.

Grifols Valuation

PE ratio
(price earnings ratio)
17.1
PS ratio (
price to sales ratio
)
2.83
PB ratio (
price to book ratio
)
3.31

Grifols Returns

ROE
(return on equity)
19%

Grifols Financial Ratios

Asset Turnover
0.39
Receivables Turnover
-
Debt to Equity
1.57
Dividend Yield
1.66%

GRFS Industry Peers

Company Price Change (%)
Ucb Sa (UCBJF)94.30 (0%)
Ipsen Sa Adr (IPSEY)42.681.27 (2.89%)
Johnson & Johnson (JNJ)140.540.58 (0.41%)
Hologic (HOLX)40.50.97 (2.45%)
Amgen (AMGN)202.341.53 (0.76%)
Kamada (KMDA)5.90 (0%)
Baxalta (BXLT)46.020.18 (0.39%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Grifols SA, Barcelona Stock News - Partner Headlines

Grifols Financial Statements

income statement20172016201520142013
Net Sales or Revenues4.88B4.48B4.37B4.46B3.64B
Net Income749.04M603.6M590.89M620.89M454.35M
Total Operating Expense1.3B1.08B1.07B1.12B905.54M
View Grifols income statement
balance sheet20172016201520142013
Total Assets12.34B11.21B10.66B11.23B7.76B
Total Liabilities8.24B7.08B7B7.69B4.96B
Shareholders Equity4.11B4.13B3.67B3.54B2.8B
View Grifols balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-74.37M-181.83M-85.56M-53.57M
Net Cash from (used by) Operating Activities951.42M612.25M824.78M1.3B786.36M
Increase (Decrease) in Prop Plant And Equipment-283.41M-273.31M-564.39M-2.02B-161.61M
View Grifols cash flow statement

Grifols Stock Message Board

An investor needs to spend $21.03 to buy GRFS stock, as the closing Grifols stock price is $21.03. Grifols market capitalization is $13.94B and it represents the total market value of GRFS stock. Grifols valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Grifols stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 562,045 GRFS shares were traded yesterday, and Grifols stock chart shows that the GRFS stock quote hit a day high of $21.07 and day low of $20.49. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Grifols stock dividend was 0.39 during the last quarter. To check the historical stock price movement, all time high, and all time low of GRFS, view Grifols stock price history.